CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+40.97%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$907M
AUM Growth
+$907M
Cap. Flow
+$30M
Cap. Flow %
3.31%
Top 10 Hldgs %
41.16%
Holding
94
New
10
Increased
12
Reduced
5
Closed
9
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ATXS icon
51
Astria Therapeutics
ATXS
$394M
$4.93M 0.54%
+800,000
New +$4.93M
INDP icon
52
Indaptus Therapeutics
INDP
$5.98M
$4.76M 0.53%
809,804
XLRN
53
DELISTED
Acceleron Pharma Inc.
XLRN
$4.61M 0.51%
127,451
OTLK icon
54
Outlook Therapeutics
OTLK
$39.5M
$4.37M 0.48%
1,027,216
RIGL icon
55
Rigel Pharmaceuticals
RIGL
$710M
$4.24M 0.47%
+1,155,600
New +$4.24M
IOVA icon
56
Iovance Biotherapeutics
IOVA
$800M
$4.16M 0.46%
505,941
ATRA icon
57
Atara Biotherapeutics
ATRA
$88.7M
$3.99M 0.44%
186,460
AGRX
58
DELISTED
Agile Therapeutics, Inc
AGRX
$3.94M 0.43%
563,880
SNDX icon
59
Syndax Pharmaceuticals
SNDX
$1.39B
$3.65M 0.4%
240,403
+25,984
+12% +$394K
CRVS icon
60
Corvus Pharmaceuticals
CRVS
$419M
$3.52M 0.39%
214,132
LPCN icon
61
Lipocine
LPCN
$15.7M
$3.35M 0.37%
751,296
IMDZ
62
DELISTED
Immune Design Corp.
IMDZ
$3.28M 0.36%
432,990
APTO
63
DELISTED
Aptose Biosciences, Inc.
APTO
$2.23M 0.25%
990,579
RGNX icon
64
Regenxbio
RGNX
$498M
$2.2M 0.24%
156,741
CBIO
65
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$2.05M 0.23%
287,031
NGNE icon
66
Neurogene
NGNE
$284M
$2.03M 0.22%
151,838
CYAD
67
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$1.79M 0.2%
75,920
EPZM
68
DELISTED
Epizyme, Inc
EPZM
$1.57M 0.17%
159,513
ASND icon
69
Ascendis Pharma
ASND
$12.1B
$1.25M 0.14%
62,254
FOLD icon
70
Amicus Therapeutics
FOLD
$2.42B
$1.12M 0.12%
151,838
AVEO
71
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$968K 0.11%
1,087,715
NSTG
72
DELISTED
NanoString Technologies, Inc.
NSTG
$809K 0.09%
40,490
MTEM
73
DELISTED
Molecular Templates, Inc.
MTEM
$686K 0.08%
1,012,255
ONSIZ
74
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$500K 0.06%
416,666
HTGM
75
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$472K 0.05%
203,464